City Therapeutics

Recent Finacing

Series B

Recent Raise

$99.5M

City Therapeutics is a biopharmaceutical company harnessing a next‑generation RNAi platform to develop RNAi‑based therapeutics.

Massachusetts, United States

11-50

Private

PitchBook

Highlights

Focus Areas

Biopharma

Life Science

Therapeutics

Recent Investors

Financials

$234.5M

Total Raised

2

Funding rounds

7

Investors

Team

Upgrade to view the team

See the team members at City Therapeutics.